annamycin has been researched along with Recrudescence in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Ford, LA; Heffner, TL; Kantarjian, HM; O'Brien, S; Parekh, S; Shepard, R; Thomas, DA; Wang, ES; Wetzler, M | 1 |
1 trial(s) available for annamycin and Recrudescence
| Article | Year |
|---|---|
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Humans; Liposomes; Male; Middle Aged; Nanoparticles; Neoplasm Grading; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Young Adult | 2013 |